Cart
sales@molnova.com
GSK 214096
CAS No. 716354-87-9
GSK 214096( GSK214096 | GSK-214096 )
Catalog No. M15739 CAS No. 716354-87-9
A potent, selective CCR5 antagonist and HIV-1 entry inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK 214096
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective CCR5 antagonist and HIV-1 entry inhibitor.
-
DescriptionA potent, selective CCR5 antagonist and HIV-1 entry inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK214096 | GSK-214096
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number716354-87-9
-
Formula Weight754.787
-
Molecular FormulaC39H46Cl2FN5O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN-(tert-butyl)-2,4-dichloro-3-(4-(3-fluorophenyl)-4-(2-((1R,3r,5S)-3-(2-methyl-1H-benzo[d]imidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl)ethyl)piperidine-1-carbonyl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kazmierski WM, et al. ACS Med Chem Lett. 2014 Oct 28;5(12):1296-9.
molnova catalog
related products
-
GSK 163929
A potent, selective CCR5 antagonist and HIV-1 entry inhibitor with pIC50 of 8.37 and 8.46 in HOS and PBL assays, respectively.
-
BMS-681
A potent and orally bioavailable dual antagonist of CCR2 and CCR5 with binding IC50 of 0.7 nM and 2.4 nM, respectively.
-
POL3026
A highly potent, selective beta-hairpin mimetic CXCR4 inhibitor with IC50 of 1.2 nM in Ca2+ flux assay.
